Home » Newsletters » BioWorld Science

BioWorld Science

July 17, 2003

View Archived Issues

ETB receptors and GIRKs: novel targets for the treatment of pain

New GSK-3 inhibitors with potential in diabetes, etc.

Gruenenthal patent covers new compounds for pain, depression, etc.

Shionogi researchers describe a novel series of HIV integrase inhibitors

New ADAM-10 inhibitors and their use in cancer and arthritis described by Exelixis

Novel NK1 antagonists for urinary incontinence and other uses in Kyorin pipeline

Noncalcemic vitamin D analogue designed by Wisconsin researchers

New anthelminthic agents patented by Kitasato Institute scientists

BMS-387032: a potent and selective CDK2 inhibitor undergoing clinical evaluation

Decolonization of the GI tract with ramoplanin: a novel option for management of VRE infection

Preclinical pharmacological activity of the novel aromatase inhibitor MEN-11066

Chiron presents antiangiogenic and antiproliferative agent targeting growth factor tyrosine kinases

Ariad compound for bone cancer/metastases a highlight of the AACR meeting

H3 Pharma acquires rights to vapreotide from Debiopharm

Patient dosing begins in Targeted Genetics' largest CF trial to date

Improved efficacy for niacin/lovastatin on lipid profile in hyperlipidemia

Santarus completes phase III patient enrollment in upper GI bleeding prevention trial

IX-1003 completes phase I testing

HCV-371 has no impact on HCV RNA levels in phase Ib study

Effective inhibition of thrombosis and moderate hemorrhage risk with melagatran in baboons

Pivotal European study of Adhibit commences enrollment

Better survival and response rate found with letrozole vs. tamoxifen in advanced breast cancer

Relationship between breast cancer risk and isoflavone consumption in Japanese women

Kosan achieves KOS-862 production goal

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 28, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...